IP Library Granted Patent US 8,987,205
Granted Patent B2
US 8,987,205 · App. 13/791,346 · Granted Mar 24, 2015

Polynucleotides encoding recombinant lubricin molecules and uses thereof

Inventors: Carl Ralph Flannery (Acton, MA); Christopher John Corcoran (Arlington, MA); Bethany Annis Freeman (Arlington, MA); Lisa A. Collins-Racie (Acton, MA)
Assignee: Wyeth LLC
C07K14/47A61K38/00A61K38/1709A61K45/06C07K14/475C07K16/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,987,205
App. No.
13/791,346
Granted
Mar 24, 2015
Kind
B2
Abstract

Recombinant lubricin molecules and uses thereof. Novel recombinant lubricin molecules and their uses as lubricants, anti-adhesive agents and/or intra-articular supplements for, e.g., synovial joints, meniscus, tendon, peritoneum, pericardium and pleura, are provided.

Claims (15)

1. An isolated protein comprising the amino acid sequence of SEQ ID NO: 15.

2. The protein of claim 1 , wherein the protein is O-linked to β-(1-3)-Gal-GalNac.

3. A composition comprising a therapeutically effective amount of a protein of claim 2 in a pharmaceutically acceptable carrier.

4. The composition of claim 3 , additionally comprising hyaluronan or hylan.

5. The composition of claim 3 , wherein the composition is formulated for injection.

6. The composition of claim 3 , wherein the composition is encapsulated.

7. The composition of claim 6 , wherein the composition is encapsulated in an implantable drug delivery matrix.

8. The composition of claim 3 , wherein the composition further comprises a local anesthetic.

9. The composition of claim 3 , wherein the composition further comprises a cytokine.

10. The composition of claim 3 , wherein the composition further comprises a lymphokine.

11. The composition of claim 3 , wherein the composition further comprises a thrombolytic factor.

12. The composition of claim 3 , wherein the composition further comprises an antithrombolytic factor.

13. The composition of claim 3 , wherein the composition further comprises an anti-inflammatory agent.

14. The composition of claim 3 , wherein the composition further comprises an antibiotic.

15. The composition of claim 3 , wherein the composition further comprises a growth factor.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 029988 FRAME 0702. ASSIGNOR(S) HEREBY CONFIRMS THE NAME BE CHANGED TO WYETH, OMIT THE LLC AS CORRECTION SHOWN ON THE ATTACHED NOTICE OF RECORDATION.. Recorded Mar 15, 2013
From: FLANNERY, CARL RALPH; CORCORAN, CHRISTOPHER JOHN; FREEMAN, BETHANY ANNIS; COLLINS-RACIE, LISA A.
To: WYETH
Reel/Frame 030004/0359 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2013
From: FLANNERY, CARL RALPH; CORCORAN, CHRISTOPHER JOHN; FREEMAN, BETHANY ANNIS; COLLINS-RACIE, LISA A.
To: WYETH LLC
Reel/Frame 029955/0702 →
CHANGE OF NAME Recorded Mar 8, 2013
From: WYETH
To: WYETH LLC
Reel/Frame 029956/0756 →
Continuity (5)
Continuation 13035529 · Feb 25, 2011
Division 12624112 · Nov 23, 2009
Division 10567764
Provisional Application 60495741 · Aug 14, 2003
Related Publication 20130196930A1 · Aug 1, 2013